Jim Cramer Says Gilead Needs to Make an Acquisition

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Gilead Sciences (GILD) - Get Report needs to ramp up its acquisition efforts. 'Biotech stocks have been in a bear market because of the presidential election,' Cramer said. 'Gilead needs to make an acquisition in order to jump-start its business.' He said the biotech group is in a bear market until the election is over.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.